These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 9248867

  • 1. A double-blind comparative study of clozapine versus chlorpromazine on Chinese patients with treatment-refractory schizophrenia.
    Hong CJ, Chen JY, Chiu HJ, Sim CB.
    Int Clin Psychopharmacol; 1997 May; 12(3):123-30. PubMed ID: 9248867
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
    Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Stern RG, Losonczy MF.
    J Clin Psychiatry; 1999 Jan; 60(1):41-4. PubMed ID: 10074877
    [Abstract] [Full Text] [Related]

  • 3. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, Klerman G.
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [Abstract] [Full Text] [Related]

  • 4. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ, Doller JC.
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [Abstract] [Full Text] [Related]

  • 14. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P.
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [Abstract] [Full Text] [Related]

  • 15. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S.
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.